Vogt PK - Search Results

1

Biochemical and biological characterization of tumor-associated mutations of p110alpha.

Denley A, Gymnopoulos M, Hart JR, Jiang H, Zhao L, Vogt PK. Denley A, et al. Among authors: vogt pk. Methods Enzymol. 2008;438:291-305. doi: 10.1016/S0076-6879(07)38020-8. Methods Enzymol. 2008. PMID: 18413256

2

Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins.

Aoki M, Jiang H, Vogt PK. Aoki M, et al. Among authors: vogt pk. Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13613-7. doi: 10.1073/pnas.0405454101. Epub 2004 Sep 1. Proc Natl Acad Sci U S A. 2004. PMID: 15342912 Free PMC article.

3

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.

Kang S, Bader AG, Vogt PK. Kang S, et al. Among authors: vogt pk. Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):802-7. doi: 10.1073/pnas.0408864102. Epub 2005 Jan 12. Proc Natl Acad Sci U S A. 2005. PMID: 15647370 Free PMC article.

4

Mutated PI 3-kinases: cancer targets on a silver platter.

Kang S, Bader AG, Zhao L, Vogt PK. Kang S, et al. Among authors: vogt pk. Cell Cycle. 2005 Apr;4(4):578-81. doi: 10.4161/cc.4.4.1586. Epub 2005 Apr 7. Cell Cycle. 2005. PMID: 15876869 Review.

5

Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins.

Vogt PK, Jiang H, Aoki M. Vogt PK, et al. Cell Cycle. 2005 Jul;4(7):908-13. doi: 10.4161/cc.4.7.1796. Epub 2005 Jul 3. Cell Cycle. 2005. PMID: 15917664 Review.

6

Oncogenic PI3K deregulates transcription and translation.

Bader AG, Kang S, Zhao L, Vogt PK. Bader AG, et al. Among authors: vogt pk. Nat Rev Cancer. 2005 Dec;5(12):921-9. doi: 10.1038/nrc1753. Nat Rev Cancer. 2005. PMID: 16341083 Review.

7

Cancer-specific mutations in PIK3CA are oncogenic in vivo.

Bader AG, Kang S, Vogt PK. Bader AG, et al. Among authors: vogt pk. Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1475-9. doi: 10.1073/pnas.0510857103. Epub 2006 Jan 23. Proc Natl Acad Sci U S A. 2006. PMID: 16432179 Free PMC article.

8

Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.

Kang S, Denley A, Vanhaesebroeck B, Vogt PK. Kang S, et al. Among authors: vogt pk. Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1289-94. doi: 10.1073/pnas.0510772103. Epub 2006 Jan 23. Proc Natl Acad Sci U S A. 2006. PMID: 16432180 Free PMC article.

9

PI 3-kinases: hidden potentials revealed.

Vogt PK, Bader AG, Kang S. Vogt PK, et al. Cell Cycle. 2006 May;5(9):946-9. doi: 10.4161/cc.5.9.2725. Epub 2006 May 1. Cell Cycle. 2006. PMID: 16687927

10

Rare cancer-specific mutations in PIK3CA show gain of function.

Gymnopoulos M, Elsliger MA, Vogt PK. Gymnopoulos M, et al. Among authors: vogt pk. Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5569-74. doi: 10.1073/pnas.0701005104. Epub 2007 Mar 21. Proc Natl Acad Sci U S A. 2007. PMID: 17376864 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters